<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">Health</journal-id><journal-title-group><journal-title>Health</journal-title></journal-title-group><issn pub-type="epub">1949-4998</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/health.2014.618280</article-id><article-id pub-id-type="publisher-id">Health-50532</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Antithrombotic Effects of Different Strains of Lactic Acid Bacteria
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>iromasa</surname><given-names>Ooe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Masaru</surname><given-names>Kato</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kanae</surname><given-names>Hyodo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Keiko</surname><given-names>Nakashima</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hiroshi</surname><given-names>Ashigai</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kyoko</surname><given-names>Kato</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Toshinori</surname><given-names>Sasaki</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yuko</surname><given-names>Fukushima</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>John</surname><given-names>C. Giddings</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Junichiro</surname><given-names>Yamamoto</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff5"><addr-line>Formerly, Department of Haematology, School of Medicine, Cardiff University, UK</addr-line></aff><aff id="aff1"><addr-line>Research Laboratories for Health Science and Food Technologies, Kirin Company, Limited, Yokohama, Japan</addr-line></aff><aff id="aff4"><addr-line>Central Laboratories for Key Technologies, Kirin Company, Limited, Yokohama, Japan</addr-line></aff><aff id="aff2"><addr-line>Research Laboratories for Brewing Technologies, Kirin Company, Limited, Yokohama, Japan</addr-line></aff><aff id="aff3"><addr-line>Laboratory of Physiology, Faculty of Nutrition, Kobe Gakuin University, Kobe, Japan</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>kmasaru@kirin.co.jp(MK)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>10</month><year>2014</year></pub-date><volume>06</volume><issue>18</issue><fpage>2433</fpage><lpage>2443</lpage><history><date date-type="received"><day>2</day>	<month>August</month>	<year>2014</year></date><date date-type="rev-recd"><day>17</day>	<month>September</month>	<year>2014</year>	</date><date date-type="accepted"><day>2</day>	<month>October</month>	<year>2014</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objective: The aim of the present study was to assess the antithrombotic properties of different strains of orally available antithrombotic lactic acid bacteria (LAB). Research Methods &amp; Procedures: Antithrombotic activity, antiplatelet reactivity and/or thrombolytic activity, were measured in seven strains of LAB and LAB cell-free-extracts (LAB filtrates) using the shear-induced platelet reactivity/thrombolytic activity, The Global Thrombosis Test (GTT), with non-anticoagulated rat blood 
  in vitro. Subsequently, the most potent antithrombotic strains identified 
  in vitro we
  re assessed in vivo after oral administration in mouse carotid arteries using a helium-neon laser-induced thrombosis model. Result: Five strains out of seven LAB (
  Lactobacillus paracasei KW 3100, 
  Lactobacillus fermentum NBRC 3961, 
  Lactobacillus pentosus JCM 8333, 
  Leuconostoc oeni Elios 1, 
  Pediococcus pentosaceus NK-2) promoted significant endogenous thrombolysis 
  in vitro. In addition, one strain (
  Lactobacillus fermentum NBRC 3961) significantly inhibited shear-induced platelet re-
  activity. Three antithrombotic strains, Lactobacillus fermentum NBRC 3961, Leuconostoc oeni Elios 1, and 
  Lactobacillus pentosus JCM 8333, were further assessed 
  in vivo. The results demonstrated that filtrates, and the cells 
  per se of these LAB, modulated antiplatelet activity and/or thrombolytic a
  ctivity, and that the antithrombotic mechanisms were mainly influenced by protein content (60% - 70% of dry matter). Conclusion: The findings suggested that some strains of lactic acid bacteria could usefully provide the basis for the production of oral antithrombotic probiotics.
 
</p></abstract><kwd-group><kwd>Antithrombotic Lactic Acid Bacteria</kwd><kwd> Shear-Induced Thrombosis</kwd><kwd> Global Thrombosis Test (GTT)</kwd><kwd> Laser-Induced Thrombosis</kwd><kwd> Endogenous Thrombolysis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Thrombus formation represents an important host defense mechanism in the physiological processes of hemostasis. Thrombus is removed naturally by the thrombolytic system during recovery, but pathologically formed thrombi can occlude blood vessels and cause atherothrombotic diseases such as myocardial infarction and stroke. Unhealthy lifestyles, including excess intake of a high-fat diet and decreased physical activity are known to be significant risk factors for thrombotic diseases [<xref ref-type="bibr" rid="scirp.50532-ref1">1</xref>] . Prevention of atherothrombosis is recognized as a serious social problem in many developed countries.</p><p>Many strains of lactic acid bacteria (LAB) have been identified since they were discovered in the 19<sup>th</sup> century. It is known that LAB are utilized in several fermented products such as liquor, pickle, yoghurt and cheese, and they are widely used as “probiotics”. Probiotics are defined as living microorganisms which provide beneficial health effects, such as improvements in gut conditions and allergic diseases, activating immune systems and reducing risk of cancers [<xref ref-type="bibr" rid="scirp.50532-ref2">2</xref>] . In Asia, LAB have been utilized in a number of fermented food products. Epidemiological investigations have shown that the incidence atherothrombotic disease is comparatively less in South- East Asia than in other developed countries [<xref ref-type="bibr" rid="scirp.50532-ref3">3</xref>] , and it has been postulated that this is partly due to an increased intake of LAB [<xref ref-type="bibr" rid="scirp.50532-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.50532-ref5">5</xref>] .</p><p>Recent studies have suggested that LAB indirectly influence thrombogenesis by inhibiting inflammatory reactions. Using a mouse model of pneumococcal pneumonia, Lactobacillus casei was shown to modulate inflammation-coagulation interactions by depressing plasminogen activator inhibitor (PAI-1) [<xref ref-type="bibr" rid="scirp.50532-ref6">6</xref>] . In addition, Bifidobacterium, a health-promoting human intestinal micro biotic, was shown to interact with the plasminogen/plas- min system in vitro [<xref ref-type="bibr" rid="scirp.50532-ref7">7</xref>] . There appears to be little information available, however, on the direct effects of LAB on thrombotic mechanisms.</p><p>Previous studies have recognized the importance of pathophysiologically relevant tests to investigate hemostasis in vivo, and techniques such as the helium-neon (He-Ne) laser-induced thrombosis test have been developed for this purpose in animal experiments [<xref ref-type="bibr" rid="scirp.50532-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.50532-ref9">9</xref>] . In addition, Kovacs et al. devised the technique of Haemostatometry [<xref ref-type="bibr" rid="scirp.50532-ref10">10</xref>] and the Global Thrombosis Test (GTT) [<xref ref-type="bibr" rid="scirp.50532-ref11">11</xref>] - [<xref ref-type="bibr" rid="scirp.50532-ref14">14</xref>] to assess physiological thrombosis in vitro, using non-anticoagulated blood. These methods are governed by shear-induced platelet activation in native blood, and have been shown to reflect the critical balance between thrombotic and thrombolytic activities [<xref ref-type="bibr" rid="scirp.50532-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.50532-ref16">16</xref>] . The GTT in particular appears to be highly reproducible and suitable for use in humans.</p><p>The present study was designed to assess antithrombotic activity, antiplatelet and thrombolytic activities, of different LAB strains using the Global Thrombosis Test (GTT) in vitro and helium-neon (He-Ne) laser-induced thrombosis test in vivo.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Animals</title><p>Male Wistar ST rats, aged 13 weeks or older (SLC Co. Ltd, Japan), and male C57BL/6 mice, aged 8 - 10 weeks (SLC Co. Lit), were used. Animals were purchased 1 week before the experiments. Rats and mice were fed a standard solid chow (CE-2, Japan Clea Co. Ltd, Japan) and allowed tap water ad libitum. Animals were maintained in compliance with the “Guiding Principles for the Care and Use of Animals in the field of Physiological Sciences,” published by Physiological Society of Japan. The protocol was approved by the Animal Experiment Committee of Kobe Gakuin University and Research Laboratories for Health Science and Food technologies, Kirin Company, Limited. Animals were sacrificed after the test by using Somnopentyl.</p></sec><sec id="s2_2"><title>2.2. Bacterial Strains</title><p>Lactobacillus fermentum strain NBRC 3961 was purchased from the National Institute of Technology and Evaluation Biological Resource Center, Japan. Lactobacillus pentosus strain JCM 8333, was obtained from the Japan Collection of Microorganisms, Japan. Pediococcus pentosaceus strain NK-2, was supplied by Biotech Japan Co. Ltd. Each of these strains is known to be found in fermented milk and vegetables. Leuconostoc oeni strain Elios 1, which is used for adding flavor to wine, was obtained from SCETI Co. Ltd, Japan, and Lactobacillus paracasei strain KW 3110, which we have previously studied for its function in immunity, was available from our own laboratory [<xref ref-type="bibr" rid="scirp.50532-ref17">17</xref>] .</p></sec><sec id="s2_3"><title>2.3. Preparation of Cells and LAB Filtrates</title><p>The Lactobacillus fermentum strain NBRC 3961, Lactobacillus pentosus strain JCM 8333, and Lactobacillus paracasei strain KW 3110 were cultured at 37˚C, 30˚C, and 30˚C, respectively for 24 h in static MRS broth (Difco, BD Bioscience, USA). Cells were harvested by centrifugation and washed with phosphate buffered saline (PBS, pH 7.4). The harvested cells were suspended and adjusted to a concentration of 10<sup>11</sup> colony forming units (CFU) with PBS. The cell suspensions were stored at 4˚C until use. To prepare LAB filtrates, the harvested cells were adjusted to 10<sup>10</sup> CFU with PBS and then incubated at 37˚C for 5 h. After incubation, cells were removed by centrifugation and the supernatant was filtered through a filter membrane with a pore size of 0.22 μm. LAB filtrates were stored at −80˚C until use.</p></sec><sec id="s2_4"><title>2.4. In Vitro Assessment of Shear-Induced Platelet Reactivity and Endogenous Thrombolytic Activity by the Global Thrombosis Test (GTT)</title><p>The GTT has been described in detail elsewhere [<xref ref-type="bibr" rid="scirp.50532-ref11">11</xref>] -[<xref ref-type="bibr" rid="scirp.50532-ref16">16</xref>] . <xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig2">Figure 2</xref> show the principles of the test. In summary, when perfectly round ceramic ball bearings are placed in the conical tube (<xref ref-type="fig" rid="fig1">Figure 1</xref>), the flat segments prevent the spheres from occluding the lumen. When blood is added to this tube, it flows through the narrow gaps caused by the ball and exits in droplets into an adjacent collecting tube. The latter is trans-illuminated by a light emitter, and a sensor opposite the emitter generates a signal whenever a drop of blood interrupts the light path. In essence, the instrument detects the time interval (d, s) between consecutive blood drops. At the start, blood flow is rapid and hence d is small. Subsequently, the flow rate gradually decreases and hence d increases. When the d exceeds 15 s (occlusion-d), the instrument displays the “Occlusion Time (OT)”, which is the time elapsed from the detection of the first drop of blood until detection of occlusion-d. Later, the flow is completely arrested. Eventually, due to thrombolysis, the flow is restored as indicated by the detection of blood drop(s). There is also an arbitrarily pre-set value of d (200 s) for lysis measurement (lysis-d). When d between the last drop before and the first drop after occlusion exceeds the value of lysis-d, the instrument displays the “Lysis Time (LT)”, which is calculated as follows: LT = [time of first drop with d &gt; (lysis-d)] − [time of last drop with d &lt; (lysis-d)]. Blood flows at 37˚C by gravity through the narrow gaps formed between the larger ball bearing and inner wall of the tube, where initial shear rates (15,000 - 18,000 s<sup>−1</sup>) activates platelets. These activated platelets remain single, because the very short transit time and high shear stress prevent aggregation. In contrast, in the space distal to the large ball bearing (i.e. the space between the two ball bearings), the shear and turbulent flow favor the formation of large platelet aggregates. Furthermore, in this space between the ball</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> The principles of the global thrombosis test</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/9-8203089x6.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Schematic diagram showing the principle of the global thrombosis test</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/9-8203089x7.png"/></fig><p>bearings, activated platelets generate thrombin and initiate blood coagulation. Flow then carries these fibrin- stabilized platelet aggregations into the lower gaps where they are captured, resulting in occlusion of the gaps and arrest of flow. An increase or decrease in OT indicates, respectively, inhibition or enhancement of platelet reactivity. An increase or decrease in LT indicates, respectively, inhibition or enhancement of spontaneous thrombolysis. For the present study, an automated GTT instrument was purchased from Montrose Diagnostics Ltd., UK. For each sample, six parallel measurements were made. The intra-individual variations on OT and LT are 6.07% and 33.67%, respectively [<xref ref-type="bibr" rid="scirp.50532-ref15">15</xref>] .</p></sec><sec id="s2_5"><title>2.5. In Vitro Effect of LAB Filtrates on Shear-Induced Platelet Reactivity and Endogenous Thrombolytic Activity</title><p>Thirty minutes after anaesthetization with somnopentyl (60 mg/kg intramuscularly), blood was withdrawn from the abdominal aorta of a rat that had been fasted overnight but allowed water ad libitum. Non-anticoagulated blood was mixed with saline kept at 37˚C (1:1), and then 2.7 ml of the diluted blood and 0.3 ml of LAB filtrate or PBS (control) were mixed by inversion in a syringe, and 3.0 ml of the mixture was applied to the GTT tube.</p></sec><sec id="s2_6"><title>2.6. In Vivo Assessment of the Antithrombotic Effect</title><p>The laser-induced thrombosis method has been previously described in detail [<xref ref-type="bibr" rid="scirp.50532-ref18">18</xref>] . In brief, mice were anaesthetized with somnopentyl (65 mg/kg intramuscularly). A polyethylene tube (PE-10, Becton Dickinson and Company, USA) was placed in the left femoral artery to inject the dye, and the carotid artery (350 - 450 &#181;m in diameter) was exposed by incision. The mouse was placed on a special microscope stage (Olympus Model BH-2, Olympus Co. Ltd, Japan), and then Evans blue dye (30 mg/kg) was injected intra-arterially. Subsequent to the dye, the centre of the exposed carotid artery was irradiated with a laser (Model Neo-50MS, 25 mW power under the objective lens, Nihon Kagaku Engineering Co. Ltd., Japan). Thrombus formation at the site of irradiation was monitored under epi-illumination and simultaneously recorded on videotape using a CCD camera (Model TMC-7, Takenaka System CO. Ltd, Japan).</p></sec><sec id="s2_7"><title>2.7. Oral Administration of LAB Filtrates and Cells in Mice</title><p>LAB filtrates, cell suspensions or PBS (control) were administered by a gastric tube in a volume of 7.7 ml/kg body weight [<xref ref-type="bibr" rid="scirp.50532-ref18">18</xref>] . They correspond to 8 &#215; 10<sup>10</sup> and 8 &#215; 10<sup>11</sup> CFU/kg body weight of LAB filtrates and cell suspensions, respectively. The same volume of LAB filtrate, cell suspension or PBS was given again 30 min after the first treatment. The mouse was then anaesthetized and thrombosis experiments started 90 min after the second oral administration. The antithrombotic or prothrombotic effect was assessed by calculation of the total thrombus size. A smaller size indicated higher antithrombotic activity [<xref ref-type="bibr" rid="scirp.50532-ref19">19</xref>] .</p></sec><sec id="s2_8"><title>2.8. Calculation of Thrombus Size</title><p>Details of this technique have been described elsewhere [<xref ref-type="bibr" rid="scirp.50532-ref20">20</xref>] . An image of the thrombus was computer-analyzed every 10 s. The area of thrombus was outlined, and the mass of thrombus was calculated by multiplication of the area and gray-scale analysis. Image analysis was performed using Image J software (Image Processing and Analysis Java version 1.30, National Institutes of Health, MD, USA). Thrombotic status was expressed as the total sum of mass measurements in the first 10 min after irradiation.</p></sec><sec id="s2_9"><title>2.9. Component Analysis of LAB Filtrates</title><p>1) Dry matter weight</p><p>The dry matter weight of LAB filtrates was measured by the freeze drying method. The NET weight was calculated by subtracting the weight of PBS used for extraction.</p><p>2) Protein assay</p><p>Protein concentration was measured using the DC protein assay kit according to the manufacturer’s instructions (Biorad, USA).</p><p>3) Saccharides</p><p>The saccharide content was measured using the phenol-sulphuric acid method with an analytical curve in glucose [<xref ref-type="bibr" rid="scirp.50532-ref21">21</xref>] .</p><p>4) Organic acids</p><p>Oxalic acid, malic acid, citric acid, succinic acid, pyruvic acid, acetic acid, lactic acid, and phosphoric acid were measured using the Agilent 7100 Capillary Electrophoresis system (Agilent Technologies, USA), with electrophoresis buffer containing 15 mM 2,6-pyridin dicarbonate, 2 mM adenosine 5’-monophosphate, and 0.035 mM hexadimethrine bromide, adjusted to pH 5.55 by NaOH.</p></sec><sec id="s2_10"><title>2.10. Mass Spectrometry Analysis and Protein Identification</title><p>Proteins contained in LAB filtrates from Lactbacillus fermentum NBRC 3961 and Lactobacillus pentosus JCM 8333 were separated in a 4% - 12% gradient SDS-PAGE gel and stained with colloidal Coomassie. The bold protein bands corresponding approximately to molecular weights of 38 kDa and 47 kDa were excised from the gel. In-gel tryptic digestion of the isolated proteins was carried out as previously described and the digested tryptic peptides were desalted using C-18 Zip-tips [<xref ref-type="bibr" rid="scirp.50532-ref22">22</xref>] . MALDI mass spectrometry was carried out on a Ultraflex II MALDI-TOF/TOF-MS spectrometer (Bruker Daltonics systems, USA). Peptide solution (0.7 μl) was mixed with 0.7 μl of 10 μg/μl HCCA (α-cyano-4-hydroxycinnamic acid) in 90% aqueous acetonitrile: 0.5% trifluoroacetic acid. The mixture (1 μl) was spotted onto a MALDI target plate and allowed to crystallize. Identification of proteins from MALDI-TOF/TOF-MS spectra was achieved using MS/MS Ion Search of Mascot (Matrix Science, USA) against SWISS-PROT database [<xref ref-type="bibr" rid="scirp.50532-ref23">23</xref>] .</p></sec><sec id="s2_11"><title>2.11. Statistical Analysis</title><p>GTT measurements were analyzed by repeated ANOVA, followed by post-hoc Dunnett’s test. Thrombus size was analyzed by unpaired ANOVA, followed by post-hoc Dunnett’s test. Values were expressed as the mean &#177; SEM. A value of P &lt; 0.05 was considered as the limit of significance.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Effect of LAB Filtrates on Shear-Induced Platelet Reactivity and Endogenous Thrombolysis in Vitro</title><p>The effects of LAB filtrates on platelet reactivity and endogenous thrombolysis are shown in <xref ref-type="table" rid="table1">Table 1</xref>. The undiluted filtrates of Lactobacillus paracasei KW 3110 and Pediococcus pentosaceus NK-2 significantly shortened LT but had no effect on OT, suggesting weak antithrombotic activity in vivo. Lactobacillus pentosus JCM 8333 and Leuconostoc oeni Elios 1 significantly shortened LT but had no effect on OT. These results suggested, however, greater antithrombotic activity in vivo compared with Lactobacillus paracasei KW 3110 and Pediococcus pentosaceus NK-2. Lactobacillus fermentum NBRC 3961 significantly prolonged OT and shortened LT, suggesting strongest antithrombotic activity in vivo amongst the LAB strains tested. On the basis of these</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Effect of LAB filtrates on shear-induced platelet reactivity and endogenous thrombolysis in vitro</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variety</th><th align="center" valign="middle" >Dilution</th><th align="center" valign="middle" >Occlusion time</th><th align="center" valign="middle" >Lysis time</th></tr></thead><tr><td align="center" valign="middle" >Lactobacillus paracasei KW 3100</td><td align="center" valign="middle" >Control &#215;100 &#215;10 &#215;1</td><td align="center" valign="middle" >275.9 &#177; 14.5 238.1 &#177; 16.7 241.6 &#177; 15.5 258.9 &#177; 18.7</td><td align="center" valign="middle" >571.6 &#177; 18.4 590.4 &#177; 31.9 469.3 &#177; 48.0 444.8 &#177; 16.0<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Lactobacillus fermentum NBRC 3961</td><td align="center" valign="middle" >Control &#215;100 &#215;10 &#215;1</td><td align="center" valign="middle" >240.6 &#177; 6.8 237.2 &#177; 7.2 241.3 &#177; 8.3 291.0 &#177; 16.8<sup>**</sup></td><td align="center" valign="middle" >597.7 &#177; 55.9 593.8 &#177; 40.8 550.5 &#177; 51.1 476.4 &#177; 34.2<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Lactobacillus pentosus JCM 8333</td><td align="center" valign="middle" >Control &#215;100 &#215;10 &#215;1</td><td align="center" valign="middle" >237.0 &#177; 12.7 242.4 &#177; 11.4 247.4 &#177; 15.1 209.0 &#177; 29.7</td><td align="center" valign="middle" >610.7 &#177; 29.2 606.5 &#177; 23.4 528.4 &#177; 25.6 307.8 &#177; 27.2<sup>**</sup></td></tr><tr><td align="center" valign="middle" >Leuconostoc oeni Elios 1</td><td align="center" valign="middle" >Control &#215;100 &#215;10 &#215;1</td><td align="center" valign="middle" >216.3 &#177; 9.8 215.2 &#177; 10.9 220.1 &#177; 10.7 216.9 &#177; 9.8</td><td align="center" valign="middle" >778.3 &#177; 45.5 635.2 &#177; 44.3<sup>*</sup> 612.4 &#177; 41.8<sup>*</sup> 518.8 &#177; 30.9<sup>**</sup></td></tr><tr><td align="center" valign="middle" >Pediococcus pentosaceus NK-2</td><td align="center" valign="middle" >Control &#215;100 &#215;10 &#215;1</td><td align="center" valign="middle" >239.1 &#177; 7.3 227.0 &#177; 5.4 226.3 &#177; 6.2 224.3 &#177; 4.0</td><td align="center" valign="middle" >645.0 &#177; 23.5 664.8 &#177; 25.1 625.8 &#177; 44.4 607.6 &#177; 43.6<sup>*</sup></td></tr></tbody></table></table-wrap><p>Filtrates from the culture media of lactic acid bacteria were mixed with non-anticoagulated rat blood (diluted two-fold with saline), and the effect on shear-induced platelet reactivity and endogenous thrombolytic activity was assessed by GTT in vitro. The results were expressed as the mean &#177; SEM. The control was PBS. <sup>*</sup>P &lt; 0.05; <sup>**</sup>P &lt; 0.01. n = 6 in each group.</p><p>findings, three strains Lactobacillus fermentum NBRC 3961, Lactobacillus pentosus JCM 8333 and Leuconostoc oeni Elios 1 were selected for further investigation in vivo.</p></sec><sec id="s3_2"><title>3.2. In Vivo Thrombotic Status after Oral Administration of LAB Filtrates</title><p>The antithrombotic effects in vivo of these three selected LAB strains were measured the He-Ne laser-induced thrombosis test in mice after oral administration. The results are shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>. The filtrate of Lactobacillus fermentum NBRC 3961 showed significantly antithrombotic effects in vivo. The filtrate of Lactobacillus pentosus JCM 8333 also showed significantly antithrombotic effects in vivo. However, the filtrate of Leuconostoc oeni Elios 1 did not show a significant antithrombotic effect in these experiments in vivo.</p></sec><sec id="s3_3"><title>3.3. In Vivo Thrombotic Status after Oral Administration of Cell Suspensions</title><p>The results are shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>. As the filtrate of Leuconostoc oeni Elios 1 did not show antithrombotic effect in vivo, this strain and others were given at a cell concentration 10 times higher than the original cell concentration of other LAB filtrate. All cell suspensions tested showed antithrombotic effect under these conditions in vivo.</p></sec><sec id="s3_4"><title>3.4. Component Analysis of LAB Filtrates</title><p>Analysis of filtrates from Lactobacillus pentosus JCM 8333 and Lactobacillus fermentum NBRC 3961 identified 80% to 90% of the ingredients in the whole dry matter weights. Protein was the main ingredient, and comprised 60% to 70% of dry matter. Organic acids (lactic acid and acetic acid) were about 5% to 10%, and saccharides were about 10% (<xref ref-type="fig" rid="fig5">Figure 5</xref>). SDS electrophoresis detected about 20 different proten bands, the most prominent of which were 38 and 47 kDa. These peptides were identified as GAPDH and enolase respectively, by MALDI- TOF/TOF-MS spectrometry analysis (<xref ref-type="fig" rid="fig6">Figure 6</xref>). The origin of the enolase in the Lactobacillus pentosus JCM 8333 filtrate was identified L. plantarum, most likely because these two species are genetically close.</p><fig-group id="fig3"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> The effect of oral administration of LAB filtrates on thrombotic status in vivo. Results are expressed as the mean &#177; SEM. The control was PBS. <sup>*</sup>P &lt; 0.05; <sup>**</sup>P &lt; 0.01. n = 6 in each group.</title></caption><fig id ="fig3_1"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/9-8203089x9.png"/></fig><fig id ="fig3_2"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/9-8203089x8.png"/></fig></fig-group><fig-group id="fig4"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> The effect of oral administration of LAB cell suspensions on thrombotic status in vivo. Results are expressed as the mean &#177; SEM. The control was PBS. <sup>*</sup>P &lt; 0.05; <sup>**</sup>P &lt; 0.01. n = 6 in each group.</title></caption><fig id ="fig4_1"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/9-8203089x11.png"/></fig><fig id ="fig4_2"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/9-8203089x10.png"/></fig></fig-group></sec></sec><sec id="s4"><title>4. Discussion</title><p>Atherothrombotic diseases are a serious medical and social problem in many developed countries. One of the most effective and economical ways to prevent atherothrombotic diseases appears to be daily intake of an antithrombotic diet. Characterising the content of diets of this nature is not straightforward, however. In the present study we employed the GTT method together with a laser-induced thrombosis model in animal experiments to investigate the potential impact of a diet including LAB products on thrombotic mechanisms. The GTT is a point-of-care test, and uses non-anticoagulated blood. Platelets in the native blood are activated by shear force, facilitating the measurement of thrombosis-risk factors by assessing platelet reactivity and thrombolytic responses. This combination tests is known to be pathophysiologically relevant to thrombosis in vivo [<xref ref-type="bibr" rid="scirp.50532-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.50532-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.50532-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.50532-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.50532-ref24">24</xref>] - [<xref ref-type="bibr" rid="scirp.50532-ref32">32</xref>] . The GTT in particular is believed to provide useful data for investigating physiological mechanisms in humans.</p><fig id="fig5"  position="float"><label><xref ref-type="fig" rid="fig5">Figure 5</xref></label><caption><title> Component analysis of LAB filtrates. The dry matter weights of LAB filtrates were measured by the freeze drying method. Protein concentration was measured using the DC protein assay kit. Saccharide content was measured by the phenol-sulphuric acid method. Organic acids were measured using the Agilent 7100 Capillary Electrophoresis system</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/9-8203089x12.png"/></fig><fig id="fig6"  position="float"><label><xref ref-type="fig" rid="fig6">Figure 6</xref></label><caption><title> Protein identification of LAB filtrates. LAB filtrates were separated by a 4% - 12% gradient gel SDS-PAGE. a, d: molecular weight merker; b: Lactobacillus pentosus JCM 8333; c: Lactobacillus fermentum NBRC 3961. The thickest bands (indicated as arrows), close to 38 and 47 kDa, were identified by MALDI-TOF/ TOF-MS spectrometry analysis, respectively</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/9-8203089x13.png"/></fig><p>The present results demonstrated that oral intake of some LAB strains had antithrombotic effects. Initially, filtrates from Lactobacillus fermentum NBRC 396, Lactobacillus pentosus JCM 8333 and Leuconostoc oeni Elios 1 were shown to significantly influence thrombolysis in vitro. The filtrate from Lactobacillus fermentum appeared also to promote antiplatelet activity in vitro. In addition, filtrates from Lactobacillus fermentum NBRC 3961 and Lactobacillus pentosus JCM 8333 were shown to mediate antithrombotic effects in vivo. Subsequently, cell suspensions from all three strains demonstrated antithrombotic activity in the in vivo model. The findings suggested that the effects of these products on hemostasis were governed by antiplatelet activity and/or thrombolytic activity.</p><p>The doses of LAB given to the animals in the present study were equivalent to ten commercial yoghurt (100 billion cells/person/day). This might be considered to be difficult to achieve in humans. Nevertheless, it is known that some LAB can survive for long periods in the intestinal tract [<xref ref-type="bibr" rid="scirp.50532-ref33">33</xref>] , and even in small quantities, active components of such LAB strains could be continually released into the intestinal tract and have beneficial effects. The antithrombotic potential appeared to be quantitatively different with various LAB strains, but the</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparison of amino acid sequences of plasminogen binding site (BS1 and BS2) of the enolase from various LABs</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Strain</th><th align="center" valign="middle" >BS1</th><th align="center" valign="middle" >BS2</th></tr></thead><tr><td align="center" valign="middle" >Lactobacillus fermentum Lactobacillus plantrum Leuconostoc oeni Pediococcus pentosaceus Lactobacillus paracasei</td><td align="center" valign="middle" >dvaaselwndedkkyklhw dcaasefyneetgkydlkg dvasselydadtkkyklk dvaaselwndedkkyklrw daaasyfynhdtknydfegk</td><td align="center" valign="middle" >-nr -sk -qg -nk -fd</td></tr></tbody></table></table-wrap><p>Lysine residues were boxed.</p><p>data indicated LABs have a common antithrombotic effect. All five of the LAB filtrates tested in vitro shortened the lysis time, and all three of the LAB suspensions tested in vivo mediated significant decreases in thrombotic status.</p><p>LAB are known to secrete organic acids, such as lactic acid, together with many functional proteins [<xref ref-type="bibr" rid="scirp.50532-ref34">34</xref>] . Our findings indicated that the main active component of Lactobacillus pentosus JCM 8333 and Lactobacillus fermentum NBRC 3961 was contained in the protein fraction. Furthermore, GAPDH and enolase appeared to be the major active peptides. Other studies have demonstrated that GAPDH and enolase on bacterial cell surfaces accelerate host invasion, and activate the plasminogen-plasmin system [<xref ref-type="bibr" rid="scirp.50532-ref35">35</xref>] - [<xref ref-type="bibr" rid="scirp.50532-ref40">40</xref>] . Moreover, direct interactions of GAPDH and enolase with plasminogen have been reported in LAB and Bifidobacteria, which are non-patho- genic organisms [<xref ref-type="bibr" rid="scirp.50532-ref41">41</xref>] [<xref ref-type="bibr" rid="scirp.50532-ref42">42</xref>] . Candela et al. reported that Bifidobacterial enolase on the cell surface has a secondary “moonlighting function” as the receptor for plasminogen in vitro. These workers and others have further emphasised that cell surface enolase might have an important role in the process of interaction with the host by influencing plasmin-related mechanisms [<xref ref-type="bibr" rid="scirp.50532-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.50532-ref42">42</xref>] [<xref ref-type="bibr" rid="scirp.50532-ref43">43</xref>] . Moreover, enolase binding sites (BS1, BS2) for plasminogen in Lactobacillus plantarum have been identified, and lysine residues appear to be important for the binding properties [<xref ref-type="bibr" rid="scirp.50532-ref42">42</xref>] . The amino acid sequences of enolase from the LAB tested in present study are shown in Ta- ble 2. BS1 lysine residues were identified in all LABs, although surrounding amino acid sequences were different. Lysine residues were not detected, however, in the C-terminal BS2 from three of the five LAB strains. Our findings suggested that the differences in antithrombotic potential of these strains might be due to distinct interactions with plasminogen, mediated by specific amino acid sequences in BS1 and BS2. Further studies are warranted to precisely characterize the active components of LAB.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The antithrombotic properties of orally available lactic acid bacteria (LAB) were assessed using shear-induced platelet reactivity/thrombolytic activity (GTT) in vitro and helium-neon laser-induced thrombosis model in vivo. The results suggested that some strains of LAB could be beneficial to prevent thrombotic disorders.</p></sec><sec id="s6"><title>Acknowledgements</title><p>The authors thank Y. Kawachi and H. Yajima, Research Laboratories for Health Science and Food technologies, Kirin Company, Limited, for comments and discussion.</p></sec><sec id="s7"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.50532-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Lichtenstein, A.H., Appel, L.J., Brands, M., Carnethon, M., Daniels, S., Franch, H.A., Franklin, B., Kris-Etherton, P., Harris, W.S., Howard, B., Karanja, N., Lefevre, M., Rudel, L., Sacks, F., Van Horn, L., Winston, M. and Wylie-Rosett, J. (2006) Summary of American Heart Association Diet and Lifestyle Recommendations Revision 2006. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 2186-2191. http://dx.doi.org/10.1161/01.ATV.0000238352.25222.5e</mixed-citation></ref><ref id="scirp.50532-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Masood, M.I., Qadir, M.I., Shirazi, J.H. and Khan, I.U. (2011) Beneficial Effects of Lactic Acid Bacteria on Human Beings. Critical Reviews in Microbiology, 37, 91-98. http://dx.doi.org/10.3109/1040841X.2010.536522</mixed-citation></ref><ref id="scirp.50532-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">White, R.H. and Keenan, C.R. (2009) Effects of Race and Ethnicity on the Incidence of Venous Thromboembolism. Thrombosis Research, 123, S11-S17. http://dx.doi.org/10.1016/S0049-3848(09)70136-7</mixed-citation></ref><ref id="scirp.50532-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Rhee, S.J., Lee, J.-E. and Lee, C.-H. (2011) Importance of Lactic Acid Bacteria in Asian Fermented Foods. Microbial Cell Factories, 10, S5. http://dx.doi.org/10.1186/1475-2859-10-S1-S5</mixed-citation></ref><ref id="scirp.50532-ref5"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tholstrup</surname><given-names> T. </given-names></name>,<etal>et al</etal>. (<year>2006</year>)<article-title>Dairy Products and Cardiovascular Disease</article-title><source> Current Opinion in Lipidology</source><volume> 17</volume>,<fpage> 1</fpage>-<lpage>10</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.50532-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Haro, C., Villena, J., Zelaya, H., Alvarez, S. and Aguero, G. (2009) Lactobacillus casei Modulates the Inflammation-Coagulation Interaction in a Pneumococcal Pneumonia Experimental Model. Journal of Inflammation, 6, 28.http://dx.doi.org/10.1186/1476-9255-6-28</mixed-citation></ref><ref id="scirp.50532-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Candela, M., Biagi, E., Centanni, M., Turroni, S., Vici, M., Musiani, F., Vitali, B., Bergmann, S., Hammerschmidt, S. and Brigidi, P. (2009) Bifidobacterial Enolase, a Cell Surface Receptor for Human Plasminogen Involved in the Interaction with the Host. Microbiology, 155, 3294-3303. http://dx.doi.org/10.1099/mic.0.028795-0</mixed-citation></ref><ref id="scirp.50532-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Kovács, I.B., Tigyi-Sebes, A., Trombitás, K. and Gorog, P. (1975) Evans Blue: An Ideal Energy-Absorbing Material to Produce Intravascular Microinjury by HE-NE Gas Laser. Microvascular Research, 10, 107-124.http://dx.doi.org/10.1016/0026-2862(75)90025-4</mixed-citation></ref><ref id="scirp.50532-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Yamamoto, J., Iizumi, H., Hirota, R., Shimonaka, K., Nagamatsu, Y., Horie, N. and Morita, S. (1989) Effect of Physical Training on Thrombotic Tendency in Rats: Decrease in Thrombotic Tendency Measured by the He-Ne Laser-Induced Thrombus Formation Method. Haemostasis, 19, 260-265.</mixed-citation></ref><ref id="scirp.50532-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ratnatunga, C.P., Edmondson, S.F., Rees, G.M. and Kovacs, I.B. (1992) High-Dose Aspirin Inhibits Shear-Induced Platelet Reaction Involving Thrombin Generation. Circulation, 85, 1077-1082. http://dx.doi.org/10.1161/01.CIR.85.3.1077</mixed-citation></ref><ref id="scirp.50532-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Yamamoto, J., Yamashita, T., Ikarugi, H., Taka, T., Hashimoto, M., Ishii, H., Watanabe, S. and Kovacs, I.B. (2003) Gorog Thrombosis Test: A Global in Vitro Test of Platelet Function and Thrombolysis. Blood Coagulation &amp; Fibrinolysis, 14, 31-39. http://dx.doi.org/10.1097/00001721-200301000-00007</mixed-citation></ref><ref id="scirp.50532-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Yamamoto, J., Inoue, N., Otsui, K., Ishii, H. and Gorog, D.A. (2014) Global Thrombosis Test (GTT) Detects Major Determinants of Hemostasis Including Platelet Reactivity, Endogenous Fibrinolytic and Thrombin Generating Potential. Thrombosis Research, 133, 919-926. http://dx.doi.org/10.1016/j.thromres.2014.02.018</mixed-citation></ref><ref id="scirp.50532-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Saraf, S., Christopoulos, C., Salha, I.B., Stott, D.J. and Gorog, D.A. (2010) Impaired Endogenous Thrombolysis in Acute Coronary Syndrome Patients Predicts Cardiovascular Death and Nonfatal Myocardial Infarction. Journal of the American College of Cardiology, 55, 2107-2115. http://dx.doi.org/10.1016/j.jacc.2010.01.033</mixed-citation></ref><ref id="scirp.50532-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Gorog, D.A., Yamamoto, J., Saraf, S., Ishii, H., Ijiri, Y., Ikarugi, H., Wellsted, D.M., Mori, M. and Yamori, Y. (2011) First Direct Comparison of Platelet Reactivity and Thrombolytic Status between Japanese and Western Volunteers: Possible Relationship to the “Japanese Paradox”. International Journal of Cardiology, 152, 43-48. http://dx.doi.org/10.1016/j.ijcard.2010.07.002</mixed-citation></ref><ref id="scirp.50532-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Yamamoto, J., Naemura, A., Ura, M., Ijiri, Y., Yamashita, T., Kurioka, A. and Koyama, A. (2006) Testing Various Fruits for Anti-Thrombotic Effect: I. Mulberries. Platelets, 17, 555-564. http://dx.doi.org/10.1080/09537100600759295</mixed-citation></ref><ref id="scirp.50532-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Yamamoto, J., Naemura, A., Ijiri, Y., Ogawa, K., Suzuki, T., Shimada, Y. and Giddings, J.C. (2008) The Antithrombotic Effects of Carrot Filtrates in Rats and Mice. Blood Coagulation &amp; Fibrinolysis, 19, 785-792. http://dx.doi.org/10.1097/MBC.0b013e3283177b19</mixed-citation></ref><ref id="scirp.50532-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Fujiwara, D., Inoue, S., Wakabayashi, H. and Fujii, T. (2004) The Anti-Allergic Effects of Lactic Acid Bacteria Are Strain Dependent and Mediated by Effects on Both Th1/Th2 Cytokine Expression and Balance. International Archives of Allergy and Immunology, 135, 205-215. http://dx.doi.org/10.1159/000081305</mixed-citation></ref><ref id="scirp.50532-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Yamamoto, J., Taka, T., Yamada, K., Ijiri, Y., Murakami, M., Hirata, Y., Naemura, A., Hashimoto, M., Yamashita, T., Oiwa, K., Seki, J., Suganuma, H., Inakuma, T. and Yoshida, T. (2003) Tomatoes Have Natural Anti-Thrombotic Effects. British Journal of Nutrition, 90, 1031-1038. http://dx.doi.org/10.1079/BJN2003994</mixed-citation></ref><ref id="scirp.50532-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Shimizu, M., Sawashita, N., Morimatsu, F., Ichikawa, J., Taguchi, Y., Ijiri, Y. and Yamamoto, J. (2009) Antithrombotic Papain-Hydrolyzed Peptides Isolated from Pork Meat. Thrombosis Research, 123, 753-757. http://dx.doi.org/10.1016/j.thromres.2008.07.005</mixed-citation></ref><ref id="scirp.50532-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Ijiri, Y., Miura, M., Hashimoto, M., Fukunaga, C., Watanabe, S., Kubota, A., Oiwa, K., Okuda, T. and Yamamoto, J. (2002) A New Model to Evaluate the Diet-Induced Prothrombotic State, Using He-Ne Laser-Induced Thrombogenesis in the Carotid Artery of Apolipoprotein E-Deficient and Low-Density Lipoprotein Receptor-Deficient Mice. Blood Coagulation &amp; Fibrinolysis, 13, 497-504. http://dx.doi.org/10.1097/00001721-200209000-00004</mixed-citation></ref><ref id="scirp.50532-ref21"><label>21</label><mixed-citation publication-type="book" xlink:type="simple">Hodge, J.E. and Hofreiter, B.T. (1962) Determination of Reducing Sugars and Carbohydrates. In: Whistler, R.L. and Wolfrom, M.L., Eds., Methods in Carbohydrate Chemistry, Vol. 1, Academic Press, New York, 380-394.</mixed-citation></ref><ref id="scirp.50532-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Gonnet, F., Lemaitre, G., Waksman, G. and Tortajada, J. (2003) MALDI/MS Peptide Mass Fingerprinting for Proteome Analysis: Identification of Hydrophobic Proteins Attached to Eucaryote Keratinocyte Cytoplasmic Membrane Using Different Matrices in Concert. Proteome Science, 1, 2. http://dx.doi.org/10.1186/1477-5956-1-2</mixed-citation></ref><ref id="scirp.50532-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Thiede, B., Hohenwarter, W., Alexander Krah, A., Mattow, J., Schmid, M., Schmidt, F. and Jungblut, P.R. (2005) Peptide Mass Fingerprinting. Methods, 35, 237-247. http://dx.doi.org/10.1016/j.ymeth.2004.08.015</mixed-citation></ref><ref id="scirp.50532-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Naemura, A., Mitani, T., Ijiri, Y., Tamura, Y., Yamashita, T. and Yamamoto, J. (2005) Anti-Thrombotic Effect of Strawberries. Blood Coagulation &amp; Fibrinolysis, 16, 501-509. http://dx.doi.org/10.1097/01.mbc.0000184737.50594.a8</mixed-citation></ref><ref id="scirp.50532-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Yamamoto, J., Yamada, K., Naemura, A., Yamashita, T. and Arai, R. (2005) Testing Various Herbs for Antithrombotic Effect. Nutrition, 21, 580-587. http://dx.doi.org/10.1016/j.nut.2004.09.016</mixed-citation></ref><ref id="scirp.50532-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Naemura, A., Ijiri, Y., Kodama, M., Honda, Y. and Yamamoto, J. (2007-2008) A Rice Variety (HYJA-Ri4) Enhances Arterial Thrombus Formation in an Animal Thrombosis Model. Patho-physiology of Haemostasis and Thrombosis, 36, 241-244. http://dx.doi.org/10.1159/000252819</mixed-citation></ref><ref id="scirp.50532-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Ichiura, D., Naemura, A., Ura, M., Mori, M. and Yamamoto, J. (2009) Anti-Thrombotic Effect of Potato in Animal Experiments. In: Food, Vol. 3, Special Issue 2, Global Science Books, 8-12.</mixed-citation></ref><ref id="scirp.50532-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Hyodo, K., Horii, I., Nishino, M., Giddings, J.C. and Yamamoto, J. (2011) The Antithrombotic Effects of Onion Filtrates in Rats and Mice. Health, 3, 319-325. http://dx.doi.org/10.4236/health.2011.36055</mixed-citation></ref><ref id="scirp.50532-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Yamamoto, J., Masuda, M., Hyodo, K. and Iwasaki, M. (2012) Experimental Antithrombotic Effect of Potatoes Harvested in the Autumn. Health, 4, 108-112. http://dx.doi.org/10.4236/health.2012.42017</mixed-citation></ref><ref id="scirp.50532-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Morishita, M., Naemura, A., Tamura, Y., Yamaya, H., Tsuda, Y., Okada, Y., Okada, K., Matsuo, O. and Yamamoto, J. (2012) Mechanism of the Experimental Antithrombotic Effect of Some Apple Varieties Involves Enhanced Endogenous Thrombolytic Activity. Interventional Medicine &amp; Applied Science, 4, 115-124.</mixed-citation></ref><ref id="scirp.50532-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Yamada, K., Naemura, A., Sawashita, N., Noguchi, Y. and Yamamoto, J. (2004) An Onion Variety Has Natural Antithrombotic Effect as Assessed by Thrombosis/Thrombolysis Models in Rodents. Thrombosis Research, 114, 213-220. http://dx.doi.org/10.1016/j.thromres.2004.06.007</mixed-citation></ref><ref id="scirp.50532-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Naemura, A., Ohira, H., Ikeda, M., Koshikawa, K., Ishii, H. and Yamamoto, J. (2006) An Experimentally Antithrombotic Strawberry Variety Is Also Effective in Humans. Pathophysiology of Haemostasis and Thrombosis, 35, 398-404. http://dx.doi.org/10.1159/000097696</mixed-citation></ref><ref id="scirp.50532-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Nishida, S., Michinaka, A., Nakashima, K., Iino, H. and Fujii, T. (2008) Evaluation of the Probiotic Potential of Lactobacillus paracasei KW3110 Based on in Vitro Tests and Oral Administration Tests in Healthy Adults. Journal of General and Applied Microbiology, 54, 267-276. http://dx.doi.org/10.2323/jgam.54.267</mixed-citation></ref><ref id="scirp.50532-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Boekhorst, J., Wels, M., Kleerebezem, M. and Siezen, R.J. (2006) The Predicted Secretome of Lactobacillus plantarum WCFS1 Sheds Light on Interactions with Its Environment. Microbiology, 152, 3175-3183. http://dx.doi.org/10.1099/mic.0.29217-0</mixed-citation></ref><ref id="scirp.50532-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Parkkinen, J. and Korhonen, T.K. (1989) Binding of Plasminogen to Escerichia coli Adhesion Protein. FEBS Letters, 250, 437-440. http://dx.doi.org/10.1016/0014-5793(89)80772-0</mixed-citation></ref><ref id="scirp.50532-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Schaumburg, J., Diekmann, O., Hagendorff, P., Bergmann, S., Rohde, M., Hammerschmidt, S., Jansch, L., Wehland, J. and Karst, U. (2004) The Cell Wall Subproteome of Listeria mono-cytogenes. Proteomics, 4, 2991-3006. http://dx.doi.org/10.1002/pmic.200400928</mixed-citation></ref><ref id="scirp.50532-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Lahteenmaki, K., Edelman, S. and Korthonen, T.K. (2005) Bacterial Metastasis: The Host Plasminogen System in Bacterial Invasion. Trends in Microbiology, 13, 79-85. http://dx.doi.org/10.1016/j.tim.2004.12.003</mixed-citation></ref><ref id="scirp.50532-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Sijbrandi, R., Den Blaauwen, T., Tame, J.R.H., Oudega, B., Luirink, J. and Otto, B.R. (2005) Characterization of an Iron-Regulated Alpha-Enolase of Bacteroides fragilis. Microbes and Infection, 7, 9-18. http://dx.doi.org/10.1016/j.micinf.2004.09.013</mixed-citation></ref><ref id="scirp.50532-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Bergmann, S. and Hammerschmidt, S. (2007) Fibrinolysis and Host Response in Bacterial Infections. Thrombosis and Haemostasis, 98, 512-520.</mixed-citation></ref><ref id="scirp.50532-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Hurmalainen, V., Edelman, S., Antikainen, J., Baumann, M., Lahteenmaki, K. and Korhonen, T.K. (2007) Extracellular Proteins of Lactobacillus crispatus Enhance Activation of Human Plasminogen. Microbiology, 153, 1112-1122. http://dx.doi.org/10.1099/mic.0.2006/000901-0</mixed-citation></ref><ref id="scirp.50532-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Candela, M., Miccoli, G., Bergmann, S., Turroni, S., Vitali, B., Hammerschmidt, S. and Brigidi, P. (2008) Plasminogen-Dependent Proteolytic Activity in Bifidobacterium lactis. Microbiology, 154, 2457-2462. http://dx.doi.org/10.1099/mic.0.2008/017095-0</mixed-citation></ref><ref id="scirp.50532-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Vastano, V., Capri, U., Candela, M., Sicilliano, R.A., Russo, L., Renda, M. and Sacco, M. (2013) Identification of Binding Sites of Lactobacillus plantarum Enolase Involved in the Interaction with Human Plasminogen. Microbiological Research, 168, 65-72. http://dx.doi.org/10.1016/j.micres.2012.10.001</mixed-citation></ref><ref id="scirp.50532-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Jeffery, C.J. (1999) Moonlighting Proteins. Trends in Biochemical Sciences, 24, 8-11. http://dx.doi.org/10.1016/S0968-0004(98)01335-8</mixed-citation></ref></ref-list></back></article>